Extending the interval of COVID-19 vaccine regimens in individuals aged 80 years or older
- PMID: 34430953
- PMCID: PMC8376211
- DOI: 10.1016/S2666-7568(21)00205-1
Extending the interval of COVID-19 vaccine regimens in individuals aged 80 years or older
Conflict of interest statement
We declare no competing interests.
Comment on
-
Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5-6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis.Lancet Healthy Longev. 2021 Sep;2(9):e554-e560. doi: 10.1016/S2666-7568(21)00169-0. Epub 2021 Aug 12. Lancet Healthy Longev. 2021. PMID: 34401865 Free PMC article.
-
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study.Lancet Healthy Longev. 2021 Sep;2(9):e544-e553. doi: 10.1016/S2666-7568(21)00168-9. Epub 2021 Aug 19. Lancet Healthy Longev. 2021. PMID: 34430954 Free PMC article.
References
-
- WHO COVID-19 vaccine tracker and landscape. July 23, 2021. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-cand...
-
- O'Driscoll M, Ribeiro Dos Santos G, Wang L. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021;590:140–145. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical